Eloxx Pharmaceuticals, Inc. (ELOX)
CIK 1035354 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 4.0M shares as of Aug 7, 2026 (10-Q). Share count fell from 231.9M to 3.2M between Aug 31, 2013 and Oct 31, 2013, a pattern consistent with a reverse split (roughly 1-for-73); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
Warrants outstanding: 7.4M underlying shares, as reported Jun 30, 2026 (10-Q).
Reported exercise price: $0.44 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $2.0M as of Mar 12, 2026.
Rough fully diluted estimate: 11.5M = 4.0M O/S + 7.4M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Hercules Term Loan Agreement | not tagged | — | $5.39 | — | — |
Notes exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 4.0M | Aug 7, 2026 |
| + Warrants (aggregate, as tagged) (if exercised) | 7.4M | Jun 30, 2026 |
| Fully diluted estimate | 11.5M | +184.2% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $50.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 2 executed · 3 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full ELOX workspace